Amrita Sule, Ph.D.
Research Scientist I
Amrita Sule is a research scientist I in Kristin Ardlie’s group in the Gene Regulation Observatory of the Ó³»´«Ã½ of MIT and Harvard. She joined the Ó³»´«Ã½ in November of 2021. She works on the , an extension of the which aims to understand gene expression similarities and contrasts during human developmental stages in multiple reference tissues.
Sule was awarded the to investigate drug combinations to target oncometabolite-producing tumors during her postdoctoral studies.
Sule received her B.Sc. and M.Sc. in life sciences from University of Mumbai, India. She obtained her Ph.D from Virginia Commonwealth University in molecular biology and biochemistry from Kristoffer Valerie’s lab. Her doctoral work focused on DNA damage response signaling focusing on the role of ATM kinase and protein phosphatase 2A in response to ionizing radiation. She then moved to Yale University as a postdoctoral associate in Ranjit Bindra’s lab where she worked on identifying combination DNA repair inhibitors and DNA damaging agents to target solid tumors.
